Published in Nephrol Dial Transplant on November 01, 1998
Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci U S A (2006) 1.87
Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest (1999) 1.84
Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest (2004) 1.31
Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. J Clin Invest (2012) 1.25
Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J Clin Invest (2002) 1.24
Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J Immunol (2008) 1.04
IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J Clin Invest (2002) 1.03
Molecules Great and Small: The Complement System. Clin J Am Soc Nephrol (2015) 0.91
Leukocytes in glomerular injury. Semin Immunopathol (2007) 0.90
Urine proteome analysis in murine nephrotoxic serum nephritis. Am J Nephrol (2009) 0.90
Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease. J Biol Chem (2013) 0.89
The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease. PLoS One (2014) 0.87
Antibody-mediated glomerulonephritis in mice: the role of endotoxin, complement and genetic background. Clin Exp Immunol (2003) 0.87
Heterogeneity of macrophage activation in anti-Thy-1.1 nephritis. Am J Pathol (2003) 0.84
Update on crescentic glomerulonephritis. Semin Immunopathol (2014) 0.82
Complement alternative pathway activation in the autologous phase of nephrotoxic serum nephritis. Am J Physiol Renal Physiol (2012) 0.81
Re-Examining Neutrophil Participation in GN. J Am Soc Nephrol (2017) 0.75
Crystal structure analysis of a complete turn of B-DNA. Nature (1980) 7.18
The structural basis of the multiple forms of human complement component C4. Cell (1984) 6.68
Structure of a B-DNA dodecamer: conformation and dynamics. Proc Natl Acad Sci U S A (1981) 6.38
High-salt d(CpGpCpG), a left-handed Z' DNA double helix. Nature (1980) 5.46
Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest (1997) 4.83
Ferricytochrome c. I. General features of the horse and bonito proteins at 2.8 A resolution. J Biol Chem (1971) 4.75
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol (1981) 4.75
Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest (1978) 4.45
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A (1995) 4.33
A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med (2000) 3.65
In situ immune complex formation and glomerular injury. Kidney Int (1980) 3.52
A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med (1998) 3.32
A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature (1984) 3.27
The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med (1982) 3.13
Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol (2000) 3.07
Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins. J Cell Biol (1975) 3.04
Identification and characterization of a proton pump on lysosomes by fluorescein-isothiocyanate-dextran fluorescence. Proc Natl Acad Sci U S A (1982) 3.03
Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation (2001) 3.03
Structure of myoglobin refined at 2-0 A resolution. I. Crystallographic refinement of metmyoglobin from sperm whale. J Mol Biol (1977) 2.99
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest (1985) 2.99
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest (1986) 2.96
Conformation change of cytochrome c. I. Ferrocytochrome c structure refined at 1.5 A resolution. J Mol Biol (1981) 2.95
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest (1986) 2.91
Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line. Nature (1985) 2.82
Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. Lab Invest (1977) 2.82
Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci U S A (1985) 2.76
Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry (1995) 2.75
Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med (1996) 2.67
Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J Biol Chem (1996) 2.67
Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med (1997) 2.61
Conformation change of cytochrome c. II. Ferricytochrome c refinement at 1.8 A and comparison with the ferrocytochrome structure. J Mol Biol (1981) 2.56
Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol (1996) 2.51
Structure of myoglobin refined at 2-0 A resolution. II. Structure of deoxymyoglobin from sperm whale. J Mol Biol (1977) 2.49
Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med (1991) 2.46
Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int (2007) 2.44
Episome-mediated Transfer of Drug Resistance in Enterobacteriaceae X. Restriction and Modification of Phages by fi R Factors. J Bacteriol (1966) 2.43
Nucleotide sequence of 4.5 S ribonucleic acid of Novikoff hepatoma cell nuclei. J Biol Chem (1972) 2.30
Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30
Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity (1996) 2.29
Bacterial mutants defective in plasmid formation: requirement for the lon + allele. Proc Natl Acad Sci U S A (1971) 2.27
Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study. Kidney Int (1999) 2.20
Involvement of a bacterial factor in morphogenesis of bacteriophage capsid. Nat New Biol (1972) 2.20
Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol (1985) (1999) 2.13
A new role for complement in experimental membranous nephropathy in rats. J Clin Invest (1980) 2.11
Structure and function of Syk protein-tyrosine kinase. J Biochem (2001) 2.09
Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region. EMBO J (1985) 2.09
Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J Clin Invest (1980) 2.07
The structure of ferrocytochrome c at 2.45 A resolution. J Biol Chem (1973) 2.00
Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J Clin Invest (1986) 2.00
Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J (1987) 2.00
Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol (2000) 1.95
Conformational changes upon reduction of cytochrome c. Cold Spring Harb Symp Quant Biol (1972) 1.94
A critical role for complement in maintenance of self-tolerance. Immunity (1998) 1.90
Structure of cytochrome c551 from Pseudomonas aeruginosa refined at 1.6 A resolution and comparison of the two redox forms. J Mol Biol (1982) 1.88
Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int (1982) 1.86
Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A (1985) 1.85
Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest (1999) 1.84
Identification and localization of polycystin, the PKD1 gene product. J Clin Invest (1996) 1.84
Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med (1996) 1.83
Intraoperative monitoring of pressure-volume loops of the left ventricle in pericardectomy for constrictive pericarditis. J Thorac Cardiovasc Surg (1996) 1.83
The effectiveness of videophones in home healthcare for the elderly. Med Care (1999) 1.79
Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med (1999) 1.79
Focal nodular hyperplasia of the liver: direct evidence of circulatory disturbances. J Gastroenterol Hepatol (2000) 1.78
Structure and organization of the C4 genes. Philos Trans R Soc Lond B Biol Sci (1984) 1.78
Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature (1997) 1.78
Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest (1989) 1.73
Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci U S A (1989) 1.73
Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem (1999) 1.73
Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci (1995) 1.68
The molecular structure of d(ICpCpGpG), a fragment of right-handed double helical A-DNA. Nature (1982) 1.68
Experimental glomerulonephritis. Methods Enzymol (1988) 1.67
Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int (1997) 1.66
Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. J Pharmacol Exp Ther (1998) 1.66
Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J Biol Chem (1997) 1.66
Lipid islands in human gastric mucosa: morphological and immunohistochemical findings. Gastroenterology (1996) 1.62
Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions. Kidney Int (1999) 1.62
The route of antigen entry determines the requirement for L-selectin during immune responses. J Exp Med (1996) 1.61
Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Genet (1999) 1.61
Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest (1983) 1.60
Glomerular permeability: in vivo tracer studies with polyanionic and polycationic ferritins. Kidney Int (1977) 1.60
Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science (1998) 1.59
Complement activation in factor D-deficient mice. Proc Natl Acad Sci U S A (2001) 1.59
Redox conformation changes in refined tuna cytochrome c. Proc Natl Acad Sci U S A (1980) 1.57
Cloning of a human complement component C4 gene. Proc Natl Acad Sci U S A (1983) 1.56
Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J Immunol (1996) 1.56
Disposable cryophake--clinical evaluation. Arch Ophthalmol (1965) 1.55
A macrophage invasion mechanism of pathogenic mycobacteria. Science (1997) 1.55
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest (1984) 1.55
Neutral endopeptidase modulation of septic shock. J Exp Med (1995) 1.53
Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J Immunol (1997) 1.52
The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics (1994) 1.52
Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med (1996) 1.52
Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol (2000) 1.51
Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology (2000) 1.50
Cefazolin, a new semisynthetic cephalosporin antibiotic. I. Synthesis and chemical properties of cefazolin. J Antibiot (Tokyo) (1970) 1.49
Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J Immunol (2001) 1.48